Skip Navigation

Project Publications: Harvard School of Public Health: Arsenic Mode of Action in Cancer: Models of Epigenetic Mechanism

Superfund Research Program

Arsenic Mode of Action in Cancer: Models of Epigenetic Mechanism

Project Leader: Karl T. Kelsey
Grant Number: P42ES005947
Funding Period: 2000 - 2006

Project-Specific Links

Connect with the Grant Recipients

Visit the grantee's eNewsletter page Visit the grantee's Twitter page

Publications

2015

  • Andrew AS, Gui J, Hu T, Wyszynski A, Marsit CJ, Kelsey KT, Schned AR, Tanyos SA, Pendleton EM, Ekstrom RM, Li Z, Zens MS, Borsuk M, Moore JH, Karagas MR. 2015. Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study. BJU Int 115(2):238-247. doi:10.1111/bju.12641 PMID:24666523 PMCID:PMC4533837
  • Andrew AS, Marsit CJ, Schned AR, Seigne JD, Kelsey KT, Moore JH, Perreard L, Karagas MR, Sempere LF. 2015. Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence. Int J Cancer 137(5):1158-1166. doi:10.1002/ijc.29413 PMID:25556547 PMCID:PMC4485975

2013

  • Eum K, Wang FT, Schwartz J, Hersh CP, Kelsey KT, Wright RO, Spiro, III A, Sparrow D, Hu H, Weisskopf MG. 2013. Modifying roles of glutathione S-transferase polymorphisms on the association between cumulative lead exposure and cognitive function. Neurotoxicology 39C:65-71. doi:10.1016/j.neuro.2013.08.002 PMID:23958642 PMCID:PMC3844089

2008

  • Andrew AS, Karagas MR, Nelson HH, Guarrera S, Polidoro S, Gamberini S, Sacerdote C, Moore JH, Kelsey KT, Demidenko E, Vineis P, Matullo G. 2008. DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy. Cancer Epidemiol Biomarkers Prev 65(2):105-118. doi:10.1159/000108942 PMID:17898541 PMCID:PMC2857629

2007

  • Hsiung DT, Marsit CJ, Houseman EA, Eddy K, Furniss CS, McClean MD, Kelsey KT. 2007. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 16(1):108-14. PMID:17220338

2006

  • Marsit CJ, Eddy K, Kelsey KT. 2006. MicroRNA responses to cellular stress. Cancer Res 66(22):10843-10848. PMID:17108120
  • Weuve J, Kelsey KT, Schwartz J, Bellinger DC, Wright RO, Rajan P, Spiro, III A, Sparrow D, Aro A, Hu H. 2006. Delta-aminolevulinic acid dehydratase polymorphism and the relation between low level lead exposure and the Mini-Mental Status Examination in older men: the Normative Aging Study. Occup Environ Med 63(11):746-753. PMID:16757504

2004

  • Danaee H, Nelson HH, Liber HL, Little JB, Kelsey KT. 2004. Low dose exposure to sodium arsenite synergistically interacts with UV radiation to induce mutations and alter DNA repair in human cells. Mutagenesis 19(2):143-148. PMID:14981161
  • Kelsey KT, Hirao T, Schned AR, Hirao S, Devi-Ashok T, Nelson HH, Andrew AS, Karagas MR. 2004. A population-based study of immunohistochemical detection of p53 alteration in bladder cancer. Br J Cancer 90(8):1572-1576. PMID:15083187
  • Kelsey KT, Park S, Nelson HH, Karagas MR. 2004. A population-based case-control study of the XRCC1 Arg399Gln polymorphism and susceptibility to bladder cancer. Cancer Epidemiol Biomarkers Prev 13(8):1337-1341. PMID:15298955
  • Ryan LM, Huang W, Thurston SW, Kelsey KT, Wiencke JK, Christiani DC. 2004. On the use of biomarkers for environmental health research. Stat Methods Med Res 13(3):207-225. PMID:15198487

2002

  • Nelson HH, Kelsey KT. 2002. The molecular epidemiology of asbestos and tobacco in lung cancer. Oncogene 21(48):7284-7288. PMID:12379872

2001

  • Danaee H, Liber HL, Nelson HH, Ebie KN, Kelsey KT. 2001. Sodium arsenate and UV induced mutation at the TK locus. Environ Mol Mutagen 37(suppl32):27.
Back
to Top